Sharechat Logo

Ebos buys Australian BlackHawk pet food business for $57.8 mln

Friday 31st October 2014

Text too small?

Ebos Group, the healthcare and animal care products company, has bought Australia's BlackHawk Premium Pet Care pet food business for $57.8 million, which it expects will immediately add to earnings.

The acquisition is part of Ebos's plan to grab market share in the premium pet food sector, which it estimates is worth $720 million in Australia alone, the Christchurch-based company said in a statement. Ebos is funding the acquisition through existing debt, and may pay more by December next year if certain earnings targets are met.

"The long-term market dynamics for animal care are very attractive and provide us with the confidence to continue to seek assets like BlackHawk to further improve shareholder returns," chief executive Patrick Davies said. "Our animal care division has a strong route to market for both pet shops and veterinarians and we look forward to further leveraging the sales growth of BlackHawk through our existing market channels to drive increased market share."

Ebos generates about 16 percent of earnings from its animal care division, which it entered in December 2011 with the $105 million acquisition of MasterPet.

The bulk of Ebos's earnings come from last year's $1.1 billion acquisition of Australian pharmaceutical firm Symbion.

In August, Ebos bought a quarter-stake in Australian pharmacy retailer Good Price Pharmacy Warehouse for an undisclosed sum.

The company will update shareholders at today's annual meeting in Christchurch.

The shares rose 1.9 percent to $9.27, and have fallen 6.2 percent this year.

 

 

 

 

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors